1. Pink Sheet

Like Sands Through The Hourglass, So Are The Days Of Woodcock’s Acting FDA Commissionership

 
• By Derrick Gingery

Janet Woodcock has been a no-nonsense acting commissioner, but there’s plenty of drama in the nomination process as opposition and support for her to become permanent head of the US FDA continues to mount while the wait for President Biden’s nominee drags on.

Unless the Biden administration nominates someone by 16 November, Janet Woodcock is halfway through her tenure as acting commissioner of the US FDA. • Source: photo illustration/Alamy images

The time that Janet Woodcock can serve as acting commissioner of the US Food and Drug Administration without someone being tapped to fill the role permanently is now more than halfway gone, upping the pressure on President Biden to find a nominee for the position.

No serious candidates, aside from Woodcock, seem to have emerged lately

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from US FDA

More from Agency Leadership